Zimbabwe has rejected a major American healthcare agreement worth $367m (272 million pounds) over five years because of Washington's insistence on sensitive biological samples.
The decision was revealed after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesperson has since stated that the US was seeking genetic material for research and commercial purposes while was not willing to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to secure a deal suitable to both sides so the nation's vital HIV treatment initiative can continue.
Broader Implications
This development follows a similar situation in Kenya, where a court blocked a similar deal with the US after legal challenges were raised about the security of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance openness and responsibility.
According to statements, 16 nations in Africa have to date signed similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our people should a new health crisis emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already set up via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our US partners on how future co-operation might be structured in a manner that honours the independence and interests of both nations."
Health Experts Response
Medical experts said it recognised the official position, but recommended that talks must proceed considering a large portion of the nation's HIV programmes relied on external financing.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it added.
The halted deal underscores the ongoing debate between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.